Simplify Logo

Internship

2025 MBA Intern

Finance

Posted on 10/30/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Cambridge, MA, USA

70/30 work model requires 70% in-office presence.

Category
Strategy Development
Business Development
Business & Strategy
Requirements
  • Currently enrolled as a 1st year in a full-time MBA program (planned graduation in Spring 2026)
  • 4+ years experience pre-MBA in healthcare consulting, pharma, biotech, or similar experience in a professional services or investment capacity (e.g., management or strategy consulting, investment banking, private equity, or venture capital)
Responsibilities
  • The Corporate Finance Team is responsible for driving the financial planning process for the company, leading the consolidation of financial statements, financial reporting, and overall budgeting and forecasting processes.
  • The team also provides strategic financial forecasting support, cash flow management, executive decision and communication support, and drives cross-functional initiatives across the finance organization.
  • The Corporate Development team is responsible for driving strategic transactions and long-term planning, focusing on initiatives that enhance the company’s technology and expand its pipeline and portfolio.
  • This includes M&A, partnerships, and licensing deals.
  • The team also collaborates cross-functionally, driving strategic projects alongside commercial, R&D, and CMC teams to support the company’s growth and innovation objectives.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?